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Abstract
The aim of this evidence-based practice project was to improve depression screening
among adolescents between the ages of 12 years and 18 years using the PHQ-9 Modified Scale
for Teens in a rural pediatric primary care clinic in Southern California. Depression is a cause of
considerable morbidity and mortality among the pediatric population. The literature supports the
use of depression screening tools in a variety of settings, including pediatric primary care; their
use has shown an improvement in the detection of depression in adolescents. The American
Academy of Pediatrics (AAP) and the U.S. Preventive Services Task Force (USPSTF)
recommend the use of tools to screen for depression in adolescents beginning at 12 years of age.
Screening tools for depression, specifically PHQ-9 Modified for Teens, help to identify
depression in both the adult and pediatric populations. With its use in pediatric primary care, the
PHQ-9 scale has been shown to have a sensitivity of 94.7% and a specificity of 86.5%. In one
pediatric primary care clinic, four clinicians, including physicians and nurse practitioners, were
educated about AAP depression screening guidelines and on the use and scoring of the PHQ-9
Modified Scale for Teens. For a period of 3 months, the screening tool was used for every wellchild visit with patients between the ages of 12 years and 18 years. Baseline data were collected
retrospectively for 3 months prior to the intervention and compared to the 3-month period
postintervention from electronic medical record (EMR). The findings demonstrated the
effectiveness of using the PHQ-9 Modified to detect depression in adolescents seen during a
well-child visit.
Keywords: adolescent depression, depression screening tool, PHQ-9, PHQ-9 modified for
teens, AAP depression guidelines, GLAD-PC.
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Depression is a cause of significant morbidity and mortality among the pediatric
population. According to the World Health Organization (2020), suicide is the third leading
cause of death in teenagers between 15 years and 19 years of age. Half of all mental health
conditions start by the age of 14 years, but most cases go undetected and untreated. Many
pediatric settings do not have a standardized process to screen for depression. The National
Institute of Mental Health (2019) estimated that, in the United States, 3.2 million adolescents 12
years to 17 years of age had at least one major depressive episode (MDE). This number
represents 13.3% of the U.S. population for this age group. In adolescents, the 12-month
prevalence of MDEs increased from 8.7% in 2005 to 11.5% in 2014 and in young adults
increased from 8.8% to 9.6%; the increase was larger and statistically significant only in the age
range of 12 years to 20 years of age. With little adaptation in mental health treatments, there is a
growing number of adolescents who live with untreated depression (Mojtabai et al., 2016).
The literature supported the use of depression screening tools in a variety of settings,
including pediatric primary care and improvements have been reported in the detection of
depression in adolescents. The American Academy of Pediatrics (AAP, 2021) and the U.S.
Preventive Services Task Force (Siu & USPSTF, 2016) recommend the use of screening tools
for depression in adolescents beginning at the age of 12 years and through the age of 18 years.
With a variety of screening tools for depression, a thorough literature revealed that these tools
help identify depression in both adults and pediatric populations, specifically the PHQ-9
Modified for Teens tool. In the pediatric primary care setting, Libby et al. (2014) reported that
the PHQ-9 scale had a sensitivity of 94.7% and a specificity of 86.5%.
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Project Purpose
The purpose of this evidence-based project was to improve depression screening among
adolescents between the ages of 12 years and 18 years using the PHQ-9 Modified for Teens scale
in a rural pediatric primary care clinic in Southern California.
Project Approval
The medical group for one pediatric clinic wrote a letter of support approving the project
and considering it a priority issue. The letter of support was then presented to the University of
San Diego’s Institutional Review Board and received approval to commence the project
(Appendix A).
Evidence-Based Model
The Iowa Model Revised (Iowa Model Collaborative et al., 2017) was used for this
evidence-based practice (EBP) project. The model provides a framework to identify a priority
topic, form a team to gather evidence, and determined whether that evidence suggests making a
practice change. The practice change must be consistent with the evidence and results are
analyzed for effectiveness. The framework loop may be used for further improvements, if no or
minimal success was shown.
Methods
Project Design
This project was designed to be led by four clinicians: two nurse practitioners and two
physicians in a rural pediatric primary care clinic. The four clinicians were educated about the
AAP depression screening guidelines and on the use and scoring of PHQ-9 Modified for Teens
scale. A paper copy of the screening form was to be handed out for every well-child visit with
pediatric patients between 12 years and 18 years of age for a period of 3 months. Patients

DEPRESSION SCREENING WITH PHQ-9 MODIFIED FOR TEENS

5

completed the form, then it was reviewed by the clinician, scored, and determined if the patient
scored positive for depression.
Baseline data were collected retrospectively via the electronic medical record (EMR) for
the 3-month period prior to screening implementation. That data were then compared to the 3month postintervention results. Data were analyzed to detect whether there was an increase in the
detection of depression in adolescents during a well-child visit after the intervention.
Plan for Treatment
For adolescents screening positive for depression, the clinicians held a discussion with
the patient and/or caregiver. In conjunction with the parent(s) and child, the clinician decided
whether the treatment for depression would commence at the primary care clinic or if a referral
would be made to a mental health specialist (e.g., psychiatric mental health nurse practitioner,
psychiatrist). If parents opted out of treatment or referral, information about mental health
services was provided (e.g., brochures, hotline phone numbers).
Measurements
The PHQ-9 Modified for Teens screens for mental health conditions including
dysthymia, suicide risk, and a range of depression (i.e., mild, moderate, moderate-severe,
severe). For the purpose of this project, the depression severity questions (Questions 1-9) were
the focus data (American Academy of Child & Adolescent Psychiatry, n.d.). Scores of from 0-4
points indicated no or minimal depression. A score of at least 5 points was a positive score for
depression. Score as high as 20-27 points (severe depression) could be obtained. Questionnaires
that had a score of 5 points or higher were included in the positive case results.
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Data Analysis
Intellectus Statistics software (2021) was used to analyze the data for this EBP project.
The pre-intervention variables were age, gender, specialty referral, specialist referral, primary
care provider (PCP) treatment, ER referral, suicidal risk, previous depression history, insurance
type, and whether depression was identified. The post-intervention variables were a verification
of the pre-intervention variables and the questionnaire score, if the score was positive for
depression.
Results
The primary aim of this EBP project was to determine whether there was an increase in
depression detection after the implementation of an evidence-based screening tool for
depression. The clinic reported 865 pre-intervention patient visits in the targeted age group with
nine of those patients scoring 5 or above on the PHQ-9 Modified. In 487 postintervention visits,
80 patients were screened and 24 patients tested positive for depression: 13 (mild), 5 (moderate),
5 (moderate-severe), and 1 (severe). To detect whether this represented a significant shift in the
proportion of depression detection, a chi-squared test was conducted with significant results (χ2 =
21.291, p < 0.001).
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Figure 1
Post-Intervention Positive Depression Cases

Limitations
The main limitation of this project was the COVID-19 pandemic. The original plan for
this EBP project was to collect data for a longer term, preferably at least 4 months
preintervention and 4 months post-intervention. With limited access to the physical location
mandated by COVID-19 restrictions, outside personnel could not go on-site for data collection.
The reduced number of patients seen postintervention was presumably the result of those
restrictions and patients’ fear of contracting the COVID-19 virus in a community setting.
Preintervention data were collected before the COVID-19 pandemic and postintervention data were collected during the pandemic. This could indicate that the rise in cases
could be related to the pandemic environment, as children were attending school virtually. These
adolescents were not interacting with peers as they would under normal circumstances and this
change could have affected their state of mental health. When compared with 2019, mental
health-related ED visits for the same period in 2020 were approximately 44% higher. During
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2019 and 2020, adolescents 12 years to 17 years of age accounted for the largest proportion of
pediatric mental health-related visits to the ED (Leeb et al., 2020).
Another limitation was that preintervention and postintervention data were not collected
during the same time of the year. Pre-intervention data consisted of visits between October 2019
and December 2019. Post-intervention data were collected between November 2020 and
February 2021.
A further limitation is that the screening tool was not built into the EMR. When patients
completed a paper copy of the PHQ-9 questionnaire for review by the clinicians, the tool was
stored in a binder; therefore, the reliability of the screening data depended on the accurate
storage of these sheets. Some questionnaires were incomplete and lacked information needed for
depression scoring.
Implications for Nursing Practice
Implementing a depression screening tool in a pediatric primary care setting may improve
the identification and treatment of depression in adolescents. Consequentially, the clinic should
be well-versed in the availability of nearby resources for referral, differences in coverage under
various health plans, and other barriers to treatment. This EBP project suggests a higher
proportion of teens are screening positive for depression, whether from the COVID-19 pandemic
or improvements in depression detection, and that may affect the limited mental health resources
in the area for appropriate and timely referrals.
For better insight on the scope and depth of teen depression, future EBP projects could
implement this screening tool in other settings or follow the same patients for longer periods.
The clinic could assign resources to track the screening process, inform providers and staff about
progress, and sustain this practice change.
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Cost-Benefit Analysis
Although reimbursement rates vary, private insurers typically allocate $15 for CPT Code
99420, Administration and interpretation of a health risk assessment instrument (e.g., health
hazard appraisal) and Medicare pays $18 for HCPCS Code G0444, Encounter for screening for
other disorder, one time per year (Savoy & O-Gurek, 2016). Approximately 80% of the patients
seen at this clinic have private insurance. Therefore, an additional $14.63 of revenue could be
generated per patient per year with PHQ-9 screening. With capitated patients, there may be a
reduction in the number of visits to the clinic. Robinson et al. (2016) reported an increase in the
number of visits for other complaints in patients with depression, translating to higher resource
utilization and costs. Decreased visits, faster referral, and timelier treatment could result in a
more efficient use of provider time, ultimately decreasing costs and resources for the clinic.
Conclusion
Depression is a leading cause of morbidity and mortality among adolescents in the United
States. A literature review supported the implementation of a depression screening tool during
well-child visits. This EBP project revealed an increased detection of depression in their
adolescent population. The use of the PHQ-9 Modified for Teens questionnaire was shown to be
beneficial in this rural pediatric primary care clinic.
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